Position in INSP
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$211,340,714
+$28,254,728 QoQ
Shares Held
4,737,519
+33.5% QoQ
Ownership
16.4%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 274 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in INSP Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026BlackRock, Inc. holds $62,872,353,779 across 116 Medical Devices names. INSP ranks #24 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
152,563,476 | $13,843,609,801 | |
| 2 | MDT |
Medtronic plc
|
114,020,787 | $8,919,846,156 | |
| 3 | SYK |
Stryker Corp
|
27,414,742 | $8,631,257,363 | |
| 4 | BSX |
Boston Scientific Corp
|
129,680,916 | $5,534,781,484 | |
| 5 | EW |
Edwards Lifesciences Corp
|
58,789,433 | $5,318,092,100 | |
| 6 | DXCM |
Dexcom Inc
|
38,244,137 | $2,575,742,616 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
37,467,843 | $2,398,316,620 | |
| 8 | STE |
STERIS plc
|
8,820,889 | $1,857,414,586 |
All Filings in INSP
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $185,712,143 | 4,163,016 | Shares | Sole | 2026-07-28 | |
| 2026-06-30 | $211,340,714 | 4,737,519 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $183,085,986 | 3,549,554 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $327,494,705 | 3,550,848 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $263,201,863 | 3,547,195 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $502,701,197 | 3,873,786 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $641,828,150 | 4,029,559 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $778,843,100 | 4,201,333 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $869,135,339 | 4,118,149 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||